A phase 2 study of sitravatinib in metastatic, pre-treated, triple negative breast cancer, NCT # 04123704

被引：0
|
作者：
Shafaee, Maryam Nemati
Otte, Kristen
Neill, Nicholas J.
Osborne, Kent C.
Westbrook, Thomas F.
Hilseneck, Susan
Ellis, Matthew J.
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-OT2-28-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-28-01
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Activity of chemotherapy based on Navelbine in pre-treated metastatic breast cancer patients
    Leusik, A
    Khodina, T
    Zhavrid, E
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S17 - S17
  • [22] Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series
    Giannone, G.
    Milani, A.
    Ghisoni, E.
    Genta, S.
    Mittica, G.
    Montemurro, F.
    Valabrega, G.
    BREAST, 2018, 38 : 160 - 164
  • [23] Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer
    Rasmussen, Maja Lynge
    Liposits, Gabor
    Yogendram, Subethini
    Jensen, Anders Bonde
    Linnet, Soren
    Langkjer, Sven Tyge
    ACTA ONCOLOGICA, 2014, 53 (09) : 1275 - +
  • [24] Phase I study of capecitabine in combination with CPT-11 for metastatic breast cancer (MBC) pre-treated with anthracycline and taxanes
    Kashiwaba, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Efficacy and safety of trastuzumab plus capecitabine in a German multicentre phase II study of pre-treated metastatic breast cancer.
    Schaller, G
    Bangemann, N
    Weber, J
    Kleine-Tebbe, A
    Beisler, GK
    Conrad, B
    Hindenburg, HJ
    Klare, P
    Ruhmland, B
    Hinke, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 57S - 57S
  • [26] A Phase 2 study of poziotinib in patients with HER2-positive metastatic breast cancer heavily pre-treated with HER2-targeted therapy
    Brufsky, Adam
    Zulfiqar, Malik
    Peguero, Julio
    Lathrop, Kate
    Bhat, Gajanan
    Lebel, Francois
    CANCER RESEARCH, 2021, 81 (04)
  • [27] Intratumoral tavokinogene telseplasmid and electroporation in pre-treated inoperable locally advanced or recurrent triple-negative breast cancer
    Telli, M. L.
    Zablotsky, K.
    Le, M. H.
    Canton, D.
    Browning, E.
    Bannavong, D.
    Gargosky, S.
    Wapnir, I.
    CANCER RESEARCH, 2019, 79 (04)
  • [28] Metastatic triple-negative breast cancer successfully treated with bicalutamide
    Eduardo Salazar-Mejia, Carlos
    Elena Garcia-Gutierrez, Maria
    Javier Rodriguez-Alvarez, Carlos
    Angel Flores-Caballero, Miguel
    Otilia Wimer-Castillo, Blanca
    Vidal-Gutierrez, Oscar
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37
  • [29] A phase II study of gemcitabine plus capecitabine (GC) in heavily pre-treated metastatic breast cancer patients. The Swedish GC Breast Cancer Study Group
    Malmstroem, A.
    Hansen, J.
    Malmberg, L.
    Carlsson, L.
    Svenssons, J. H.
    Ahlgren, J.
    Ahlin, C.
    Jansson, T.
    Westberg, R.
    EJC SUPPLEMENTS, 2008, 6 (07): : 175 - 176
  • [30] Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer
    Fenn, Kathleen
    Maurer, Matthew
    Lee, Shing M.
    Crew, Katherine D.
    Trivedi, Meghna S.
    Accordino, Melissa K.
    Hershman, Dawn L.
    Kalinsky, Kevin
    CLINICAL BREAST CANCER, 2020, 20 (01) : 80 - 86
12345